End Brain Cancer Initiative adds Dr. Morana Vojnic to medical advisory board

The End Brain Cancer Initiative named Dr. Morana Vojnic to its Medical Advisory Board on June 25, 2026, adding a neuro-oncology leader as the nonprofit expands education and support for patients with primary and metastatic brain tumors. The move comes as the group says its patient case load is growing among people whose cancer has spread to the brain.

Why it matters: - Dr. Morana Vojnic brings neuro-oncology expertise to a nonprofit focused on patient access, education and improved standard of care. - The appointment is aimed at strengthening support for patients with metastatic brain disease, a growing part of EBCI’s patient case load. - EBCI says the addition will help expand education programs and services for patients with cancer that has spread to the brain.

What happened: - The End Brain Cancer Initiative announced on June 25, 2026, that Dr. Morana Vojnic has joined its Medical Advisory Board. - Dr. Vojnic serves as Director of Neuro-Oncology at Rutgers Cancer Institute and System Leader for Neuro-Oncology at RWJBarnabas Health. - EBCI is a 501(c)3 non-profit patient advocacy organization.

The details: - Dr. Vojnic focuses on multidisciplinary clinical care, clinical trials and research for patients with primary and metastatic brain tumors. - EBCI President and CEO Dellann Elliott Mydland said Dr. Vojnic’s expertise in metastatic brain tumors and precision oncology makes her a valuable addition to the board. - Mydland said Dr. Vojnic will help build out patient education programs and services for metastatic disease. - EBCI says it works to increase patient access, improve standard of care and support equal access to advanced diagnostics, treatments, specialists and clinical trial participation. - The organization says it partners with industry, patients, researchers, advocacy groups, medical teams and hospital networks to help patients and caregivers prepare for conversations with clinicians. - EBCI said it has been a leader in patient advocacy, education and support for more than 24 years. - The nonprofit was formerly known as the Chris Elliott Fund. - EBCI asks supporters to consider a $50 donation at the donation page.

Between the lines: - The appointment signals that EBCI is leaning more heavily into metastatic brain disease, not just primary brain cancer. - Bringing in a specialist with clinical, trial and research experience may help the organization align patient education more closely with current treatment pathways. - The board addition also suggests EBCI is trying to match its advocacy work to a more complex and growing patient population.

What's next: - EBCI said Dr. Vojnic will help expand education programs and services for metastatic disease. - The organization expects the board addition to support better patient education, access and outcomes. - EBCI also said the partnership will help fuel research in this disease state.

The bottom line: - EBCI is adding specialized medical expertise as it broadens its focus on patients whose brain cancer has metastasized, signaling a stronger push on education, access and research.